|
Oral
Presentation -February 3, 2020- Monday
Time 15:45 to 16:45 (Total oral presenters
-6) |
|
 |
Dr. Sandeep
Singh
National Institute of Biomedical Genomics, Kalyani, India
Heterocellular
reciprocation-based identification of molecular targets against oral cancer
progression |
|
|
Dr. Kusum K Singh
Indian Institute of Technology, Guwahati, India
"EJC-RNPS1 masks cryptic splice sites to
safeguard transcriptome integrity |
|
|
Dr. Thoudam
Debraj Singh
All India Institute of Medical Sciences New
Delhi, India
A
Novel Orally Active Inverse Agonist of Estrogen-Related Receptor Gamma (ERRγ),
DN200434, Enhances Sodium Iodide Symporter Function in Anaplastic Thyroid
Cancer Model
|
|
|
Dr. Pratibha
Srivastava
Agharkar Research
Institute, Pune, India
Unexplored Flavones: Role
in Anticancer Activity |
|
|
Dr. Mayank Singh
All India Institute
of Medical Sciences, New Delhi, India
Validation of Ubiquitin Specific
Peptidase 37 (USP37) as a critical factor in Oncogenesis of Osteosarcoma
|
|
|
Dr. Amit Sehrawat
All India Institute of Medical Sciences, Rishikesh, India
Paraneoplastic transaminitis - A rare
manifestation of ovarian cancer
|
|
Oral Presentation -February 4, 2020 Tuesday
Time 12:30 to 13:00 (Total
oral presenters
-3)
|
|
|
Dr. Nirmala Jagadish
National Institute of
Immunology, New Delhi, India
Targeted
therapy: Future perspectives of SPAG9 in breast cancer
|
|
|
Dr. Anil Mukund
Limaye
Indian Institute of Technology, Guwahati, India
DNA
Methylation Mediated Silencing of GPER1: Implications in Breast and
Colon Cancer |
|
|
Dr.
Manraj Singh Kang
Guru Gobind Singh Medical
College & Hospital, Faridkot, India
Clinical feasibility of high dose rate interstitial brachytherapy
|
|
Oral Presentation -February 4, 2020 Tuesday
Time 15:30 to 15:50 (Total oral presenters
-2)
|
|
|
Dr. Priyanka Samji
Indian Institute of Technology,
Chennai,
India
miRNA profiling and analysis of
signaling pathways following curcumin treatment in cervical cancer cells
|
|
|
Ms. Apoorva Uboveja
Dr B. R. Ambedkar Center for Biomedical
Research, University of Delhi, New Delhi, India
Neuron Navigator-3, a direct transcriptional
target of p73, plays a critical role in p73 mediated suppression of
colon cancer cell migration,invasion and metastasis.
|
|
Oral Presentation -February 5, 2020-Wednesday
Time 12:30 to 13:00 (Total oral presenters
-3)
|
|
|
Dr. Pratima Solanki
Assistant Professor, Jawaharlal Nehru
University, New Delhi, India
Potential of Nanomaterials
materials for Cancer Biomarkers detection
|
|
 |
Dr. Tushar Vora
Tata Memorial Centre, Mumbai, India
Comparison
of treatment plans feasible through AI enabled multidisciplinary online
tumor board solution vs. NCCN based Clinical Decision Support System (CDSS)
|
|
|
Dr. Anil Kumar
National Institute of
Immunology. New Delhi, India
Towards understanding the link between intestinal
microbiota and colorectal cancer |
|
Oral Presentation- February 5, 2020- Wednesday
Time 15:30 to 16:00 (Total
oral presenters -4)
|
|
 |
Ms. Kavya Vipparthi
National Institute of Biomedical Genomics Kalyani, India
Phenotypic
heterogeneity of subpopulations reveals hierarchical yet plastic nature
of tumor cells in gingivobuccal carcinoma
|
|
 |
Dr. Ashok Sharma
All India Institute
of Medical Sciences, New Delhi, India
Epigenetic regulation of POTE
genes in Epithelial
Ovarian Cancer
|
|
|
Dr.
Garima Jain
Banaras Hindu University, Varanasi, India
Guggulsterone
mediated regulation of homeobox gene NKX3.1 in prostate cancer
|
|
 |
Dr.
Rinu Sharma
GGSIP University, New Delhi, India
Insights into the role of E3
ubiquitin ligase, MARCH8, in esophageal cancer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
